Shaban, Muhammad
Bai, Yunhao
Qiu, Huaying
Mao, Shulin
Yeung, Jason
Yeo, Yao Yu http://orcid.org/0000-0002-7604-2296
Shanmugam, Vignesh
Chen, Han
Zhu, Bokai
Weirather, Jason L.
Nolan, Garry P. http://orcid.org/0000-0002-8862-9043
Shipp, Margaret A. http://orcid.org/0000-0002-3949-6897
Rodig, Scott J.
Jiang, Sizun http://orcid.org/0000-0001-6149-3142
Mahmood, Faisal http://orcid.org/0000-0001-7587-1562
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-002704)
U.S. Department of Health & Human Services | National Institutes of Health (DP2AI171139, R01AI149672)
Gilead’s Research Scholars Program in Hematologic Malignancies
U.S. Department of Health & Human Services | National Institutes of Health (R35GM138216)
Fredrik och Ingrid Thurings Stiftelse
Fredrick National Laboratory
U.S. Department of Health & Human Services | National Institutes of Health (R35GM138216)
Fredrick National Laboratory
Rachford and Carlota A. Harris Endowed Professorship
Blood Cancer Discoveries Grant Program from the Leukemia Lymphoma Society, The Mark Foundation, and The Paul G. Allen Frontiers Group
Blood Cancer Discoveries Grant Program from the Leukemia Lymphoma Society, The Mark Foundation, and The Paul G. Allen Frontiers Group
Article History
Received: 15 May 2023
Accepted: 1 December 2023
First Online: 2 January 2024
Competing interests
: S.J.R. has received research support from Affimed, Merck, and Bristol-Myers Squibb (BMS), he is on the Scientific Advisory Board for Immunitas Therapeutics and part of Bristol Myers Squibb International Immuno-Oncology Network (II-ON). M.A.S. has research funding from BMS, Bayer, Abbvie, and AstraZeneca, and is on advisory boards for AstraZeneca and BMS. G.P.N. is co-founder and stockholder of IonPath Inc, which manufactures the instrument used in this manuscript, is a co-founder and stockholder of Akoya Biosciences, Inc. and inventor on patent US9909167, and is a Scientific Advisory Board member for Akoya Biosciences, Inc. S.J. has received research funding from Roche, Gilead, and Sanofi not related to this work. The other authors declare no competing interests.